Genentech’s Columvi meets primary endpoint in Phase 3 Study
In the Phase 3 study, Columvi plus chemotherapy showed a statistically significant improvement in overall survival (OS), progression-free…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
15 Apr 24
In the Phase 3 study, Columvi plus chemotherapy showed a statistically significant improvement in overall survival (OS), progression-free…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
12 Apr 24
Point of Care HIV diagnostic testing for infants and early detection of HIV infections
12 Apr 24
Greenspace's measurement-based care platform will integrate with Welligent's cloud-based EHR software for behavioural health.
12 Apr 24
The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life…
10 Apr 24
The partnership will see the integration of advanced spinal implants with AI-powered surgical guidance systems.
10 Apr 24
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a series of new products to further enhance…
10 Apr 24
Educational sessions explore solving analytical challenges with innovative products
10 Apr 24
The TumorSight Plan tool provides advanced visualisation, data-driven insights, and best practices for surgeons.
10 Apr 24
The FDA has granted de novo classification to the robotic system for soft tissue manipulation in microsurgery.
10 Apr 24
Greenway Clinical Assist integrates Nabla's ambient AI assistant with Greenway's Prime Suite and Intergy EHR.